Óscar Arrieta
About
Óscar Arrieta is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology.
According to data from OpenAlex, Óscar Arrieta has authored 390 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 209 papers in Oncology, 197 papers in Pulmonary and Respiratory Medicine and 76 papers in Molecular Biology. Recurrent topics in Óscar Arrieta's work include Lung Cancer Treatments and Mutations (149 papers), Lung Cancer Research Studies (86 papers) and Lung Cancer Diagnosis and Treatment (59 papers). Óscar Arrieta is often cited by papers focused on Lung Cancer Treatments and Mutations (149 papers), Lung Cancer Research Studies (86 papers) and Lung Cancer Diagnosis and Treatment (59 papers). Óscar Arrieta collaborates with scholars based in Mexico, Colombia and United States. Óscar Arrieta's co-authors include Andrés F. Cardona, Julio Sotelo, Diana Flores‐Estrada, Zyanya Lucía Zatarain-Barrón, Horacio Astudillo‐de la Vega, Norma Hernández‐Pedro, Karla Sánchez-Lara, Jenny G. Turcott, Cynthia Villarreal‐Garza and Carolina Núñez-Valencia and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Óscar Arrieta
348 papers receiving 8.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Óscar Arrieta Mexico | 48 | 3.7k | 3.2k | 2.3k | 1.5k | 710 | 390 | 8.4k | ||
| Emilio Bria Italy | 46 | 4.0k 1.1× | 2.8k 0.9× | 1.8k 0.8× | 1.5k 1.0× | 618 0.9× | 392 | 7.1k | ||
| Ann G. Schwartz United States | 58 | 4.3k 1.2× | 3.5k 1.1× | 2.5k 1.1× | 1.8k 1.3× | 500 0.7× | 291 | 10.8k | ||
| Javier de Castro Spain | 40 | 4.1k 1.1× | 3.0k 0.9× | 3.1k 1.4× | 1.5k 1.0× | 420 0.6× | 304 | 8.3k | ||
| Letícia Nogueira United States | 26 | 3.0k 0.8× | 1.6k 0.5× | 1.9k 0.8× | 1.2k 0.8× | 388 0.5× | 131 | 7.4k | ||
| Antônio Rossi Italy | 45 | 3.9k 1.1× | 3.8k 1.2× | 2.3k 1.0× | 1.1k 0.7× | 493 0.7× | 365 | 8.3k | ||
| Boštjan Šeruga Canada | 34 | 4.4k 1.2× | 1.8k 0.6× | 1.2k 0.5× | 1.6k 1.1× | 736 1.0× | 124 | 7.4k | ||
| Hyunsoon Cho South Korea | 29 | 2.8k 0.8× | 1.6k 0.5× | 1.5k 0.6× | 868 0.6× | 357 0.5× | 83 | 6.8k | ||
| Emanuela Scarpi Italy | 46 | 3.5k 0.9× | 1.8k 0.6× | 1.2k 0.5× | 1.4k 1.0× | 445 0.6× | 265 | 7.0k | ||
| Amanda L. Blackford United States | 48 | 3.6k 1.0× | 1.4k 0.4× | 1.7k 0.8× | 1.3k 0.9× | 748 1.1× | 227 | 7.5k | ||
| Elsken van der Wall Netherlands | 54 | 4.1k 1.1× | 1.9k 0.6× | 3.9k 1.7× | 4.1k 2.8× | 574 0.8× | 240 | 11.1k |
Countries citing papers authored by Óscar Arrieta
Since
Specialization
Citations
This map shows the geographic impact of Óscar Arrieta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Óscar Arrieta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Óscar Arrieta more than expected).
Fields of papers citing papers by Óscar Arrieta
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Óscar Arrieta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Óscar Arrieta. The network helps show where Óscar Arrieta may publish in the future.
Co-authorship network of co-authors of Óscar Arrieta
This figure shows the co-authorship network connecting the top 25 collaborators of Óscar Arrieta. A scholar is included among the top collaborators of Óscar Arrieta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Óscar Arrieta. Óscar Arrieta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Arrieta, Óscar, Juan‐Manuel Hernandez‐Martinez, Jenny G. Turcott, et al.. (2025). Narrowing the Gap: Understanding Lung Cancer Care Intervals and Their Barriers in Latin American Low and Middle-Income Countries. Archives of Medical Research. 56(5). 103202–103202.
2.
Mendoza-Milla, Criselda, et al.. (2025). SMARCB1-driven EGFR-GLI1 epigenetic alterations in lung cancer progression and therapy are differentially modulated by MEOX2 and GLI-1. Cancer Gene Therapy. 32(3). 327–342.
3.
Flores‐Estrada, Diana, et al.. (2025). Immunomodulatory role of oncogenic alterations in non-small cell lung cancer: a review of implications for immunotherapy. Cancer and Metastasis Reviews. 44(1). 30–30.
4.
Arrieta, Óscar, Luis Lara‐Mejía, Andrés F. Cardona, et al.. (2025). Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial. Nature Communications. 16(1). 4553–4553.
5.
Cabrera‐Galeana, Paula, Santiago Ávila‐Ríos, Margarita Matías‐Florentino, et al.. (2025). Correction: Rodríguez-Bautista et al. Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior. Cancers 2021, 13, 6256. Cancers. 17(19). 3212–3212.
6.
Lima, Vladmir Cláudio Cordeiro de, Aline Fusco Fares, Marcelo Corassa, et al.. (2024). Real-world characteristics and outcomes of ERBB2- mutant NSCLC in Latin American patients (CLICaP). The Oncologist. 30(2).
7.
Hernández‐Pedro, Norma, Pedro Barrios‐Bernal, Santiago Ávila‐Ríos, et al.. (2023). Impact of KRASG12D subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes. Clinical & Translational Oncology. 26(4). 836–850.
8.
Aguirre, Elena, Diego Enrico, Diego Kaen, et al.. (2023). P2.18-04 Real-world Study on Efficacy of First-Line Nivolumab + Ipilimumab in Unresectable Malignant Pleural Mesothelioma (ImmunoMeso). Journal of Thoracic Oncology. 18(11). S382–S382.
9.
Viola, Lucía, et al.. (2023). Recomendaciones para el diagnóstico, seguimiento y tratamiento cáncer del pulmón de células no pequeñas temprano en Colombia. 45(4). 767–804.
10.
Calderón, Jaqueline, et al.. (2023). Childhood acute lymphoblastic leukemia survival and spatial analysis of socio-environmental risks in Mexico. Frontiers in Oncology. 13. 1236942–1236942.
11.
Ordóñez‐Reyes, Camila, Juan Esteban García-Robledo, Alejandro Ruíz-Patiño, et al.. (2022). Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question. Pharmaceutics. 14(6). 1243–1243.
12.
Werutsky, Gustavo, Carlos H. Barrios, Andrés F. Cardona, et al.. (2021). Perspectives on emerging technologies, personalised medicine, and clinical research for cancer control in Latin America and the Caribbean. The Lancet Oncology. 22(11). e488–e500.
13.
Maldonado, F., Luis F. Oñate‐Ocaña, Zyanya Lucía Zatarain-Barrón, et al.. (2021). Prophylactic Cranial Irradiation in Patients With High-Risk Metastatic Non-Small Cell Lung Cancer: Quality of Life and Neurocognitive Analysis of a Randomized Phase II Study. International Journal of Radiation Oncology*Biology*Physics. 111(1). 81–92.
14.
Munoz-Moñtano, Wendy, Paula Cabrera‐Galeana, Cynthia De la Garza‐Ramos, et al.. (2021). Prognosis of breast cancer diagnosed during pregnancy and early postpartum according to immunohistochemical subtype: A matched case–control study. Breast Cancer Research and Treatment. 188(2). 489–500.
15.
Blake-Cerda, M., Luis Lara‐Mejía, Zyanya Lucía Zatarain-Barrón, et al.. (2020). Consolidative stereotactic ablative radiotherapy (SABR) to intrapulmonary lesions is associated with prolonged progression-free survival and overall survival in oligometastatic NSCLC patients: A prospective phase 2 study. Lung Cancer. 152. 119–126.
16.
Carrot‐Zhang, Jian, Giovanny Soca‐Chafre, Nick Patterson, et al.. (2020). Genetic Ancestry Contributes to Somatic Mutations in Lung Cancers from Admixed Latin American Populations. Cancer Discovery. 11(3). 591–598.
17.
Ángel, Martín, Renata Colombo Bonadio, Guilherme Harada, et al.. (2020). Mentoring as an opportunity to improve research and cancer care in Latin America (AAZPIRE project). ESMO Open. 5(6). e000988–e000988.
18.
Muñiz‐Hernández, Saé, et al.. (2015). Alterations in Retinoic Acid Receptors in Non-Small Cell Lung Cancer and Their Clinical Implications. Journal of Cancer Therapy. 6(8). 648–664.
19.
Lara-Medina, Fernando, Víctor M. Pérez-Sánchez, David Saavedra-Pérez, et al.. (2011). Triple‐negative breast cancer in Hispanic patients. Cancer. 117(16). 3658–3669.
20.
Arrieta, Óscar, et al.. (2002). Antiproliferative effect of thalidomide alone and combined with carmustine against C6 rat glioma. International Journal of Experimental Pathology. 83(2). 99–104.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Emilio Bria Breakdown of academic impact, for papers by Ann G. Schwartz Breakdown of academic impact, for papers by Javier de Castro Breakdown of academic impact, for papers by Letícia Nogueira Breakdown of academic impact, for papers by Antônio Rossi Breakdown of academic impact, for papers by Boštjan Šeruga Breakdown of academic impact, for papers by Hyunsoon Cho Breakdown of academic impact, for papers by Emanuela Scarpi Breakdown of academic impact, for papers by Amanda L. Blackford Breakdown of academic impact, for papers by Elsken van der Wall